ThomasXuefengLuMD

Gastroenterology • Bloomington, IN

Inflammatory Bowel Disease

Physician

Join to view full profile

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lu's full profile

Already have an account?

Office
550 S Landmark Ave
Bloomington, IN 47403
Phone+1 812-333-5973

Summary

Dr. Thomas Lu is a gastroenterologist in Bloomington, IN and is affiliated with Indiana University Health - Bloomington. He received his medical degree from University of Cincinnati College of Medicine and completed his Internal Medicine residency and Gastroenterology fellowship training at the University of Chicago Medicine. He specializes in inflammatory bowel disease.

Education & Training

University of ChicagoFellowship, Gastroenterology, 2015 - 2019
University of ChicagoResidency, Internal Medicine, 2013 - 2015
University of Cincinnati College of MedicineClass of 2013

Certifications & Licensure

IL State Medical License 2013 - 2026
IN State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

13 citations
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controll...
Thomas X. Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba
Gut. 2021-11-01
286 citations
MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity.
Thomas X. Lu, Jochen C. Hartner, Eunjin Lim, Victoria Fabry, Melissa K. Mingler
Journal of Immunology. 2011-09-15
81 citations
A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T Cells.
Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui-Lung Sun, Marc Bissonnette
Cellular and Molecular Gastroenterology and Hepatology. 2020-01-01

Journal Articles

The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controll...
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba, Gut, 12/17/2020